Abstract
Bisphosphonates (BPs) are widely used as anti-bone-resorptive agents. Despite the great benefits of BPs, they may cause local and systemic adverse side effects. The aim of this study was to evaluate the histopathological effect zoledronic acid (ZA), which belongs to BPs, has on the intrinsic tongue muscles in a rat model. A total of 30 adult male albino rats were divided into 3 groups (10 rats each): group I served as a control; group II was given an intraperitoneal (i.p.) injection of 0.2 mg/kg of ZA once per week for 3 weeks; and group III received the same dosage of ZA, but for 8 weeks. After the animals were euthanized, the tongue tissue was dissected and examined histologically, histochemically and immunohistochemically. Histologically, a normal architecture of the muscle fascicles was observed in the control group. Group II showed degenerated muscle fibers with an indistinct sarcolemma. In group III, the muscle fibers were degenerated with severe sarcoplasmic dissolution. The histochemical examination using Masson's trichrome (MT) demonstrated a significant increase in collagen fibers in groups II and III as compared to the control group. The immunohistochemical results revealed a statistically significantly higher expression of nuclear factor kappa B (NF‑κB) in the ZA-treated groups (II and III) as compared to the control group, with the highest mean value recorded in group III. Zoledronic acid induced histopathological changes to the intrinsic tongue muscles, and this effect was exaggerated with a longer duration of administration.
Highlights
Bisphosphonates (BPs) are a class of drugs that are widely used in the treatment of osteoclast-mediated bone loss.[1]
In group III, the muscle fibers were degenerated with severe sarcoplasmic dissolution
Zoledronic acid induced histopathological changes to the intrinsic tongue muscles, and this effect was exaggerated with a longer duration of administration
Summary
Bisphosphonates (BPs) are a class of drugs that are widely used in the treatment of osteoclast-mediated bone loss.[1]. They are synthetic, stable analogs of inorganic pyrophosphates – naturally occurring polyphosphates found in urine and blood serum. Of all the antibone-resorptive BPs available nowadays, those containing nitrogen in the heterocyclic ring (zoledronic acid – ZA) are 10,000 times more potent than non-N-BPs.[5]. Zoledronic acid is well-established as a therapy for reducing skeletal-related events associated with bone metastases in several types of cancer, including prostate cancer.[6]. Several adverse effects have been demonstrated to be associated with ZA treatment. Bisphosphonates (BPs) are widely used as anti-bone-resorptive agents. Despite the great benefits of BPs, they may cause local and systemic adverse side effects
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
